| Literature DB >> 32817339 |
Wael Awad1,2, Erin W Meermeier3, Maria L Sandoval-Romero1, Jérôme Le Nours1,2, Aneta H Worley4, Megan D Null5, Ligong Liu6,7, James McCluskey8, David P Fairlie6,7, David M Lewinsohn3,4,9, Jamie Rossjohn10,2,11.
Abstract
MR1 presents vitamin B-related metabolites to mucosal associated invariant T (MAIT) cells, which are characterized, in part, by the TRAV1-2+ αβ T cell receptor (TCR). In addition, a more diverse TRAV1-2- MR1-restricted T cell repertoire exists that can possess altered specificity for MR1 antigens. However, the molecular basis of how such TRAV1-2- TCRs interact with MR1-antigen complexes remains unclear. Here, we describe how a TRAV12-2+ TCR (termed D462-E4) recognizes an MR1-antigen complex. We report the crystal structures of the unliganded D462-E4 TCR and its complex with MR1 presenting the riboflavin-based antigen 5-OP-RU. Here, the TRBV29-1 β-chain of the D462-E4 TCR binds over the F'-pocket of MR1, whereby the complementarity-determining region (CDR) 3β loop surrounded and projected into the F'-pocket. Nevertheless, the CDR3β loop anchored proximal to the MR1 A'-pocket and mediated direct contact with the 5-OP-RU antigen. The D462-E4 TCR footprint on MR1 contrasted that of the TRAV1-2+ and TRAV36+ TCRs' docking topologies on MR1. Accordingly, diverse MR1-restricted T cell repertoire reveals differential docking modalities on MR1, thus providing greater scope for differing antigen specificities.Entities:
Keywords: : Antigen presentation; MAIT; MHC-related molecule (MR1); T-cell receptor (TCR); atypical MAIT TCR; crystal structure; immunology; major histocompatibility complex (MHC); protein structure; receptor structure-function
Mesh:
Substances:
Year: 2020 PMID: 32817339 PMCID: PMC7573270 DOI: 10.1074/jbc.RA120.015292
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157